SEPTInvestingStart Free

AVBP 8-K: Executive departure

Filed with the SEC on · accession 0001104659-26-124484

AVBP filed a 8-K (current report) with the SEC on Nov 9, 2026. ArriVent BioPharma President of Research and Development and director Stuart Lutzker, M.D., Ph.D. notified the company of his retirement effective December 1, 2026. The stock moved +3.8% by the first close after the filing.

Summary of the filing

ArriVent BioPharma President of Research and Development and director Stuart Lutzker, M.D., Ph.D. notified the company of his retirement effective December 1, 2026. Chief Medical Officer Priti Patel, M.D. will assume leadership of the research and development function.

For details, click here →How to read a 8-K →

Key details

One-time retirement payment to Dr. Lutzker$428K
RegistrantArriVent BioPharma, Inc.
President, research and development and directorStuart Lutzker, M.D., Ph.D.
Chief medical officerPriti Patel, M.D.
Chief financial officer and treasurerWinston Kung

How AVBP stock reacted

Close before

$13.64

Nov 6, 2026

First close after

+3.81%

$14.16

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for AVBP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AVBP?

Click here

Frequently asked questions

What did AVBP file with the SEC on Nov 9, 2026?

AVBP filed a 8-K (Executive departure). ArriVent BioPharma President of Research and Development and director Stuart Lutzker, M.D., Ph.D. notified the company of his retirement effective December 1, 2026. Chief Medical Officer Priti Patel, M.D. will assume leadership of the research and development function.

What does a executive departure mean for AVBP stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did AVBP stock react to this filing?

AVBP closed at $13.64 before the filing and $14.16 on Nov 9, 2026 (+3.81%).

Other AVBP SEC filings

Get alerts when AVBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
AVBP overviewAVBP analysisAVBP newsLatest SEC filings